journal article·2021-08

Neutrophil Decoys with Anti‐Inflammatory and Anti‐Oxidative Properties Reduce Secondary Spinal Cord Injury and Improve Neurological Functional Recovery

Yihui Bi, Wenxiu Duan, Jing Chen, Tao You, Shuya Li, Wei Jiang, Min Li, Gang Wang, Xueyin Pan, Jiang Wu, Dan Liu, Jun Li, Yucai Wang

Advanced Functional Materials· Volume 31· Issue 34
Publisher page

Abstract

Abstract Following spinal cord injury (SCI), immune cell infiltration creates an inflammatory and oxidative microenvironment (known as the secondary injury), which causes neuron death and spinal cord damage, and dramatically hinders neurological functional recovery. Strategies that inhibit the infiltration and/or function of neutrophils offer promises for SCI treatment because they can reduce the secondary injury; however, such strategies remain largely unexplored. Herein, a strategy using neutrophil membrane‐coated nanoparticles (NPs) as decoys (neutrophil decoy, ND) is presented to reduce local neutrophil infiltration and relieve oxidative stress in the injured spinal cord after SCI. Coated with membranes of activated neutrophils, the NDs inherit multiple receptors from the “parent” neutrophils, which can adsorb and neutralize the elevated neutrophil‐related cytokines. In addition, polydopamine NPs with multi‐antioxidative properties (selected as the core for ND) scavenge excessive reactive oxygen and nitrogen species. In a contusion model of SCI, ND treatment significantly reduces neutrophil infiltration and reprograms the inflammatory and oxidative microenvironment in injured spinal cords. Importantly, ND treatment significantly improves neural regeneration and functional recovery in rats. Such a nano‐decoy platform opens up new approaches for efficiently treating SCI.
Source: crossref · Quality: baseline

Research context

OpenAlex topics: Spinal Cord Injury Research · Aortic Disease and Treatment Approaches · Neuroinflammation and Neurodegeneration Mechanisms

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

Inflammation and Immune Mediated Diseases Laboratory of Anhui Province Anhui Institute of Innovative Drugs School of Pharmacy Anhui Medical University Hefei 230032 China

Division of Molecular Medicine Hefei National Laboratory for Physical Sciences at Microscale The CAS Key Laboratory of Innate Immunity and Chronic Disease School of Life Sciences University of Science and Technology of China Hefei 230027 China

Department of Interventional Radiology The First Affiliated Hospital of USTC Division of Life Sciences and Medicine University of Science and Technology of China Hefei 230001 China

School of Life Science Hefei Normal University Hefei 230601 China

The First Affiliated Hospital of USTC Division of Life Sciences and Medicine University of Science and Technology of China Hefei 230001 China

Funding

National Natural Science Foundation of China · Fundamental Research Funds for the Central Universities · China Postdoctoral Science Foundation

References (68)

Show source-provided references
1. 10.1038/nrdp.2017.1810.1038/nrdp.2017.18 ↗
2. 10.1038/s41582-020-0311-010.1038/s41582-020-0311-0 ↗
3. 10.1038/nrn195510.1038/nrn1955 ↗
4. 10.1016/j.pneurobio.2013.11.00210.1016/j.pneurobio.2013.11.002 ↗
5. 10.1016/S0140-6736(14)60687-510.1016/S0140-6736(14)60687-5 ↗
6. 10.1016/j.jot.2019.10.00610.1016/j.jot.2019.10.006 ↗
7. 10.1056/NEJMra151653910.1056/NEJMra1516539 ↗
8. 10.1186/s12984-018-0386-710.1186/s12984-018-0386-7 ↗
9. 10.1007/s13311-018-0632-510.1007/s13311-018-0632-5 ↗
10. 10.1152/physrev.00017.201710.1152/physrev.00017.2017 ↗
11. 10.1038/nm0709-73610.1038/nm0709-736 ↗
12. 10.1212/WNL.000000000000799810.1212/WNL.0000000000007998 ↗
13. 10.1016/j.neuron.2015.05.01910.1016/j.neuron.2015.05.019 ↗
14. 10.1093/brain/awl29610.1093/brain/awl296 ↗
15. 10.1016/j.neuron.2017.07.01010.1016/j.neuron.2017.07.010 ↗
16. 10.1038/s41467-019-13812-z10.1038/s41467-019-13812-z ↗
17. 10.1111/j.1600-065X.2012.01127.x10.1111/j.1600-065X.2012.01127.x ↗
18. 10.1038/nri339910.1038/nri3399 ↗
19. 10.1016/j.nantod.2017.08.00610.1016/j.nantod.2017.08.006 ↗
20. 10.1038/nrneurol.2017.1310.1038/nrneurol.2017.13 ↗
21. 10.1016/j.tins.2015.08.00210.1016/j.tins.2015.08.002 ↗
22. 10.1016/j.it.2020.07.00710.1016/j.it.2020.07.007 ↗
23. 10.1038/s41590-020-00812-110.1038/s41590-020-00812-1 ↗
24. 10.1523/JNEUROSCI.4918-08.200910.1523/JNEUROSCI.4918-08.2009 ↗
25. 10.1172/jci.insight.9825410.1172/jci.insight.98254 ↗
26. 10.1523/ENEURO.0101-18.201810.1523/ENEURO.0101-18.2018 ↗
27. 10.1038/sc.2010.12710.1038/sc.2010.127 ↗
28. 10.1523/JNEUROSCI.5343-03.200410.1523/JNEUROSCI.5343-03.2004 ↗
29. 10.1523/JNEUROSCI.2785-16.201710.1523/JNEUROSCI.2785-16.2017 ↗
30. 10.1093/brain/awp30410.1093/brain/awp304 ↗
31. 10.1038/s41573-019-0054-z10.1038/s41573-019-0054-z ↗
32. 10.1016/j.it.2015.07.00710.1016/j.it.2015.07.007 ↗
33. 10.1016/S1074-7613(00)80165-X10.1016/S1074-7613(00)80165-X ↗
34. 10.1016/j.cell.2010.02.02910.1016/j.cell.2010.02.029 ↗
35. 10.1038/sc.2011.11110.1038/sc.2011.111 ↗
36. 10.1073/pnas.100992610710.1073/pnas.1009926107 ↗
37. 10.1016/j.jconrel.2019.12.00110.1016/j.jconrel.2019.12.001 ↗
38. 10.1002/adfm.20190483310.1002/adfm.201904833 ↗
39. 10.1002/advs.20170003410.1002/advs.201700034 ↗
40. 10.1002/adfm.20060123710.1002/adfm.200601237 ↗
41. 10.1016/j.pain.2013.05.01810.1016/j.pain.2013.05.018 ↗
42. 10.1002/adma.20170675910.1002/adma.201706759 ↗
43. 10.1002/adma.20170624510.1002/adma.201706245 ↗
44. 10.1038/s41565-018-0254-410.1038/s41565-018-0254-4 ↗
45. 10.1002/adfm.20180353110.1002/adfm.201803531 ↗
46. 10.1002/adfm.20200355910.1002/adfm.202003559 ↗
47. 10.1021/acs.nanolett.9b0375310.1021/acs.nanolett.9b03753 ↗
48. 10.1002/adma.20120468310.1002/adma.201204683 ↗
49. 10.1021/jacs.6b1101310.1021/jacs.6b11013 ↗
50. 10.3390/ma1307173010.3390/ma13071730 ↗
51. 10.1038/s41467-019-13854-310.1038/s41467-019-13854-3 ↗
52. 10.1016/j.tips.2015.04.00310.1016/j.tips.2015.04.003 ↗
53. 10.1038/nrrheum.2015.16110.1038/nrrheum.2015.161 ↗
54. 10.1016/j.immuni.2010.07.00910.1016/j.immuni.2010.07.009 ↗
55. 10.3389/fimmu.2019.0106810.3389/fimmu.2019.01068 ↗
56. 10.1089/ars.2012.514910.1089/ars.2012.5149 ↗
57. 10.1016/j.freeradbiomed.2011.09.03010.1016/j.freeradbiomed.2011.09.030 ↗
58. 10.3171/FOC.2008.25.11.E510.3171/FOC.2008.25.11.E5 ↗
59. 10.1016/j.immuni.2017.06.00610.1016/j.immuni.2017.06.006 ↗
60. 10.1021/acsnano.9b0678010.1021/acsnano.9b06780 ↗
61. 10.1021/acs.nanolett.8b0402010.1021/acs.nanolett.8b04020 ↗
62. 10.1038/nature1397410.1038/nature13974 ↗
63. 10.1152/ajpcell.00139.200410.1152/ajpcell.00139.2004 ↗
64. 10.1523/JNEUROSCI.2484-15.201510.1523/JNEUROSCI.2484-15.2015 ↗
65. 10.1038/nrn259110.1038/nrn2591 ↗
66. 10.1089/neu.1995.12.110.1089/neu.1995.12.1 ↗
67. 10.1073/pnas.182027611610.1073/pnas.1820276116 ↗
68. 10.1016/j.ymthe.2018.04.02210.1016/j.ymthe.2018.04.022 ↗